Advertisement
ALP vs DYAI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALP is a Hold and DYAI is a Hold.
Momentum Indicator for ALP turns negative, indicating new downward trend
ALP saw its Momentum Indicator move below the 0 level on October 02, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned negative. In 82 of the 87 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day moving average for ALP crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ALP entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for ALP just turned positive on October 08, 2026. Looking at past instances where ALP's MACD turned positive, the stock continued to rise in 40 of 43 cases over the following month. The odds of a continued upward trend are 90%.
Following a +28.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALP advanced for three days, in 166 of 202 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.348) is normal, around the industry mean (2.409). P/E Ratio (-0.528) is within average values for comparable stocks, (-3.173). Projected Growth (PEG Ratio) (0.360) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.271) among similar stocks. P/S Ratio (7.752) is also within normal values, averaging (15.798).
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. ALP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
DYAI's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for DYAI turned positive on September 18, 2026. Looking at past instances where DYAI's MACD turned positive, the stock continued to rise in 43 of 49 cases over the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DYAI's RSI Oscillator exited the oversold zone, 23 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 59 of 71 cases where DYAI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
Following a +4.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where DYAI advanced for three days, in 181 of 217 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
DYAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DYAI as a result. In 77 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The 50-day moving average for DYAI moved below the 200-day moving average on September 21, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DYAI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for DYAI entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. DYAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-6.696) is normal, around the industry mean (3.035). P/E Ratio (-1.900) is within average values for comparable stocks, (-1.360). Projected Growth (PEG Ratio) (52.360) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (10.893) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DYAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ALP | DYAI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 95 | 87 | |
P/E GROWTH RATING 1..100 | 7 | 7 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALP's Valuation (85) in the null industry is in the same range as DYAI (97) in the Biotechnology industry. This means that ALP’s stock grew similarly to DYAI’s over the last 12 months.
ALP's Profit vs Risk Rating (100) in the null industry is in the same range as DYAI (100) in the Biotechnology industry. This means that ALP’s stock grew similarly to DYAI’s over the last 12 months.
ALP's SMR Rating (100) in the null industry is in the same range as DYAI (100) in the Biotechnology industry. This means that ALP’s stock grew similarly to DYAI’s over the last 12 months.
DYAI's Price Growth Rating (87) in the Biotechnology industry is in the same range as ALP (95) in the null industry. This means that DYAI’s stock grew similarly to ALP’s over the last 12 months.
DYAI's P/E Growth Rating (7) in the Biotechnology industry is in the same range as ALP (7) in the null industry. This means that DYAI’s stock grew similarly to ALP’s over the last 12 months.
| ALP | DYAI | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 77% |
| Stochastic ODDS (%) | 2 days ago 85% | 2 days ago 83% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| MACD ODDS (%) | 2 days ago 90% | 5 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 86% |
| Advances ODDS (%) | about 1 month ago 82% | 3 days ago 83% |
| Declines ODDS (%) | 3 days ago 90% | 6 days ago 86% |
| BollingerBands ODDS (%) | N/A | 2 days ago 84% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 79% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALP’s FA Score shows that 1 FA rating(s) are green while DYAI’s FA Score has 1 green FA rating(s).
- ALP’s FA Score: 1 green, 4 red.
- DYAI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALP’s TA Score shows that 2 TA indicator(s) are bullish while DYAI’s TA Score has 5 bullish TA indicator(s).
- ALP’s TA Score: 2 bullish, 4 bearish.
- DYAI’s TA Score: 5 bullish, 4 bearish.
Price Growth
ALP (@Investment Managers) experienced а -11.18% price change this week, while DYAI (@Biotechnology) price change was -2.94% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was -0.72%. For the same industry, the average monthly price growth was -6.44%, and the average quarterly price growth was -2.12%.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.
Reported Earning Dates
ALP is expected to report earnings on Nov 25, 2026.
DYAI is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Investment Managers (-0.72% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
@Biotechnology (+1.24% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ALP and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALP has been loosely correlated with BENF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ALP jumps, then BENF could also see price increases.
| Ticker / NAME | Correlation To ALP | 1D Price Change % | ||
|---|---|---|---|---|
| ALP | 100% | +1.68% | ||
| BENF - ALP | 33% Loosely correlated | -6.52% | ||
| SPRB - ALP | 30% Poorly correlated | -1.85% | ||
| CYPH - ALP | 29% Poorly correlated | -5.37% | ||
| DYAI - ALP | 29% Poorly correlated | -0.75% | ||
| CORT - ALP | 29% Poorly correlated | -20.13% | ||
More | ||||